2,199 results on '"Mandelli F"'
Search Results
2. Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
3. Thermal adaptation strategies of the extremophile bacterium Thermus filiformis based on multi-omics analysis
4. Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes
5. Characterization and Low-Resolution Structure of an Extremely Thermostable Esterase of Potential Biotechnological Interest from Pyrococcus furiosus
6. PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy
7. The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia
8. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
9. Intensive Chemotherapy Followed by Stem Cell Transplantation for the Treatment of Myelodysplastic Syndromes
10. Alternativa chirurgica mini-invasiva mediante l’utilizzo di impianti angolati dopo scollamento e dislocazione posteriore della membrana del seno
11. High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT
12. Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes
13. Poor-Risk Acute Myelogenous Leukemia Patients Undergoing the Fludarabine – Cytosine Arabinoside – Filgrastim Regimen: Multidrug Resistance Expression, Granulocyte Colony-Stimulating Factor Priming Activity and Clinical Response
14. Postremission Therapy: The Role of Allogeneic Bone Marrow Transplantation in Acute Myelogenous Leukemia: An Analysis of the AML8A EORTC-GIMEMA Protocol
15. Intensified Early Therapy for Childhood Acute Myeloid Leukemia: Pilot Studies of the AIEOP Cooperative Group
16. Treatment of Acute Lymphoblastic Leukemia in the Elderly: Results of the GIMEMA 0288> 60 Years Trial
17. Therapy of Adult Acute Lymphoblastic Leukemia. Preliminary Results of the GIMEMA ALL/0288 Study
18. Interleukin-2-Based Immunotherapy in the Management of Minimal Residual Disease in Acute Leukemia Patients
19. Molecular Diagnosis and Monitoring of Acute Promyelocytic Leukemia: Updated Results of the Italian Gimema Group
20. Interleukin 2 Treatment in the Management of Acute Leukemia Patients
21. VERY LONG-TERM RESULTS OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE IN NON-HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA: LATEST UPDATE OF THE ITALIAN-GERMAN APL0406 RANDOMIZED TRIAL
22. Non-Hodgkin’s Lymphomas in Patients with AIDS
23. Therapy of Acute Myelogenous Leukemia in Adults
24. Therapy of Childhood Acute Myelogenous Leukemia: An Update of the AIEOP/LAM 8204 Study
25. Interferon-α2b as Therapy for Untreated and Pretreated Patients with Ph1 Positive Chronic Myelogenous Leukemia
26. Interleukin-2 (IL-2) in Acute Leukemia: In Vitro Studies and Possible Clinical Applications
27. In Vitro and In Vivo Inhibitory Effects of Interferon α 2b on CML Granuloerythroid Precursors
28. Expression of Cellular Oncogenes in Primary Cells from Human Acute Leukemias
29. Translocation and Rearrangement of c-myc into Immunoglobulin α Heavy Chain Locus in Primary Cells from Acute Lymphocytic Leukemia
30. Recombinant Human Erythropoietin After Bone Marrow Transplantation — A Placebo Controlled Trial
31. Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib
32. Mitoxantrone, Etoposide, and Intermediate-Dose Cytosine Arabinoside (MEC): An Effective Regimen for Refractory Acute Myeloid Leukemia
33. VERY LONG-TERM RESULTS OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE IN NON-HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA: LATEST UPDATE OF THE ITALIAN-GERMAN APL0406 RANDOMIZED TRIAL
34. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features
35. Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial
36. Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups
37. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia
38. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation
39. Accidental falls in home care hematological patients
40. Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease
41. High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias
42. Treatment of elderly patients (≥60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols
43. Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen
44. The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
45. The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
46. The characterization of a thermostable and cambialistic superoxide dismutase from Thermus filiformis
47. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol
48. Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia
49. Acute megakaryoblastic leukemia: experience of GIMEMA trials
50. Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.